Forbion European Acquisition Corp. (FRBN)

NASDAQ: FRBN · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Nov 25, 2022 12:59 PM
+0.09 (0.88%)
After-hours: Nov 25, 2022 1:00 PM EST
Market Cap 161.45M
Revenue (ttm) n/a
Net Income (ttm) -142,025
Shares Out 15.81M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 102
Open 10.21
Previous Close 10.21
Day's Range 10.21 - 10.21
52-Week Range 9.86 - 10.55
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About FRBN

Forbion European Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify opportunities in the life sciences industry in Europe. The company was incorporated in 2021 and is based in Wilmington, Delaware. [Read more]

Industry Blank Check / SPAC
IPO Date Dec 10, 2021
Employees 2,021
Stock Exchange NASDAQ
Ticker Symbol FRBN
Full Company Profile


Forbion European Acquisition Corp. Announces Pricing of $110 Million Initial Public Offering

Forbion European Acquisition Corp. today announced the pricing of its initial public offering of 11,000,000 units at a price of $10.00 per unit.

11 months ago - PRNewswire

Dutch venture firm's SPAC Forbion European Acquisition files for a $100 million IPO

Forbion European Acquisition, a blank check company formed by Forbion targeting the life sciences industry in Europe, filed on Tuesday with the SEC to raise up to $100 million in an initial public offer...

1 year ago - Renaissance Capital

Forbion European Acquisition IPO Registration Document (S-1)

Forbion European Acquisition Corp. has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC